Healthcare
For over 30 years, we have supported our clients – leaders in the healthcare sector (pharmaceutical industry players, biotechs, medical device companies, diagnostic companies, players in vaccines and animal health) – and have developed recognized expertise in numerous domains in this sector.
To go further
Healthcare
What are the 5 key challenges of digital care pathways?
Challenge n°1: embracing organizational change to successfully implement digital care pathways Change in workflows and processes Digitalizing the patient pathway requires a fundamental change in ...
Healthcare
Microbiome and cancer: exploring the influence of the human microbiome on cancer development and progression
Which cancers are related to the microbiome? The complex interplay between the human microbiome and cancer has become a focal point of contemporary medical research. As we delve deeper into specific ...
Healthcare
2 challenges to overcome in clinical trials for rare diseases to maximize the development of new treatments
Challenge n°1: Develop knowledge about rare diseases Research into rare diseases is hampered by a lack of knowledge of the biological mechanisms involved and a limited understanding of how these ...
Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.
Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.
Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.
Our dream? To build a team of 1,000 explorers, to design tomorrow’s world hand in hand with our clients.
Value-based healthcare highlights the importance of emphasizing health outcomes of treatment relative to its costs and has been first described by the academic Michael Porter. The focus in care in this model is shifting away from quantity of care i.e. purely providing services to the patients, towards quality of care, i.e. providing high-quality medical care for patients that optimally increases also their quality of life.
Patient centricity is a global approach bringing together several dimensions. Nevertheless, the essential principle is to position the patient at the heart of the concerns of healthcare players (pharma companies,…), to anticipate and better meet their needs by considering them as a partner, and no longer a spectator, from the development stage of the products that will concern said patient. The main objective of patient-centric approaches is thus to make the patient the actor of his or her own health, while promoting continuity of care and fluid management.
Personalized medicine is defined as medical treatments tailored to the individual characteristics of each patient. It uses the individual’s genetic and phenotypic profile to guide decisions made on disease prevention, diagnosis, and treatment. Very recently, behavorial and social science has been used to add a new dimension to individual profiling.
In regenerative medicine, damaged and diseased tissues are replaced using advanced techniques such as stem cells, gene therapy, and tissue engineering to restore normal function. This field is ground-breaking as it allows for important therapeutic applications.
Digital health, or eHealth, is a technological and cultural transformation of healthcare utilizing digital approaches . The topic covers a breadth of topics such as digital therapeutics (DTx), artificial intelligence in health, connected objects or the IoT. In summary, digital health is any use of information and communication technologies in health with the goal of optimizing care pathways.